Longitudinal study on activated factors XII and VII levels during normal pregnancy
- 1 January 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 100 (1) , 40-44
- https://doi.org/10.1046/j.1365-2141.1998.00514.x
Abstract
Levels of activated factor XII (FXIIa) and VII (FVIIa) were determined in 100 women with uneventful pregnancies. Samples were divided into five study intervals: three during pregnancy, one at delivery and one 3 d postpartum. The median (range) for FXIIa levels were 3.4 ng/ml (1.2–9.1) from 11 to 20 weeks, 4.6 ng/ml (1.4–15.2) from 21 to 30 weeks, 5.4 ng/ml (1.9–14.3) from 31st week to delivery, 5.2 (1.3–11.4) at delivery and 4.3 (1.8–8.5) ng/ml in the postpartum sample. For FVIIa the median and range levels for the five periods were 4.9 (1.7–77.3), 7.2 (2.5–80.4), 11.1 (2.9–90.6), 12.0 (3.1–64.1) and 8.2 (4.0–23.5) ng/ml. Although the increase of FVIIa was higher than that of FXIIa during pregnancy, the overall changes of FXIIa and FVIIa were highly correlated (P < 0.0001). At each time period the changes of FVIIa correlated with FVII:C which was not the case with FVII:Ag. These data indicate that during pregnancy both the contact phase and extrinsic pathway are activated.Keywords
This publication has 24 references indexed in Scilit:
- Population Correlates of Coagulation Factor VIIArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Measurement of activated factor XII in health and diseaseBlood Coagulation & Fibrinolysis, 1996
- An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Activated Factor XII (Hageman Factor) in Human PlasmaJournal of Immunoassay, 1996
- State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic StrategiesClinical and Applied Thrombosis/hemostasis, 1995
- Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- PREGNANCY AND FACTOR VIIBritish Journal of Haematology, 1992
- Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Is factor VII activation in pregnant women relevant to fetal growth retardation?Thrombosis Research, 1987
- Clotting factor VII during pregnancy, delivery and puerperiumBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Studies on Blood Coagulation and Fibrinolysis in Pregnancy, during Delivery and in the PuerperiumGynecologic and Obstetric Investigation, 1981